Psychiatry and Neurology, Neurology · Atlanta, GA
NPI
1427219609
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
6135 Barfield Rd Ste 200
Atlanta, GA, 30328
Phone (404) 256-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
7,918 services
Medicare patients, 2024
363
Average age 76
Drug cost, 2024
$1.1M
2,120 prescriptions
Company payments, 2025
$1,097
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jacqueline W Green was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,790 times for 14 patients. In total Jacqueline W Green billed 7,918 services in 57 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,790 | 14 | $4.99 | $34K |
| 99214 Office E&M - Established | Office | 266 | 190 | $92.85 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 236 | 204 | $12.81 | $3,022 |
| 99204 Office E&M - New | Office | 119 | 119 | $118.63 | $14K |
| 82607 Clinical Chemistry | Office | 41 | 39 | $14.78 | $606 |
| 99213 Office E&M - Established | Office | 34 | 33 | $65.12 | $2,214 |
| 64615 Musculoskeletal | Office | 33 | 14 | $123.36 | $4,071 |
| 99215 Office E&M - Established | Office | 22 | 21 | $133.85 | $2,945 |
| 95886 Electrical Nerve Conductivity | Office | 19 | 12 | $75.47 | $1,434 |
| 80053 Clinical Chemistry | Office | 19 | 16 | $10.35 | $197 |
| 85025 Blood Count | Office | 18 | 17 | $7.61 | $137 |
| 99203 Office E&M - New | Office | 17 | 17 | $74.44 | $1,266 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 16 | $32.05 | $513 |
| 90662 Vaccine Product | Office | 14 | 14 | $81.82 | $1,145 |
| 95910 Electrical Nerve Conductivity | Office | 12 | 12 | $132.75 | $1,593 |
By year: 2022 $85K for 5,268 services; 2023 $95K for 7,143 services; 2024 $102K for 7,918 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82607 Clinical Chemistry | 41 | 39 | $14.78 | $606 |
| 80053 Clinical Chemistry | 19 | 16 | $10.35 | $197 |
| 85025 Blood Count | 18 | 17 | $7.61 | $137 |
Medicare prescription drug claims, 2024
In 2024, the drug Jacqueline W Green prescribed most often to Medicare patients was Gabapentin, with 224 prescriptions and refills. In total Jacqueline W Green wrote 2,120 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 224 | 330 | 56 | $3,035 |
| Donepezil Hcl Generic | 212 | 415 | 61 | $1,580 |
| Memantine Hcl Generic | 179 | 319 | 50 | $5,544 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 176 | 294 | 48 | $3,422 |
| Sertraline Hcl Generic | 118 | 204 | 29 | $561 |
| Propranolol Hcl Generic | 70 | 102 | 15 | $605 |
| Pregabalin Generic | 58 | 67 | 13 | $1,690 |
| Levetiracetam Generic | 51 | 112 | 14 | $1,616 |
| Topiramate Generic | 48 | 75 | 14 | $310 |
| Duloxetine Hcl Generic | 48 | 78 | 11 | $629 |
| Lacosamide Generic | 46 | 58 | Under 11 | $1,055 |
| Ubrelvy Ubrogepant | 37 | 37 | Under 11 | $54K |
| Primidone Generic | 34 | 50 | Under 11 | $439 |
| Emgality Pen Galcanezumab-Gnlm | 33 | 33 | Under 11 | $23K |
| Clopidogrel Clopidogrel Bisulfate | 31 | 63 | Under 11 | $369 |
Brand drugs: - claims; generic drugs: 1,883 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacqueline W Green $1,097 ($1,097 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $379.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $379 |
| Pfizer Inc. PFE | 10 | $186 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $59.77 |
| Biogen, Inc. BIIB | 2 | $48.81 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $44.71 |
| Neurelis, Inc. | 2 | $42.08 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $38.41 |
| Amgen Inc. AMGN | 2 | $36.89 |
| Axsome Therapeutics, Inc. AXSM | 1 | $34.76 |
| LivaNova USA, Inc. LIVN | 1 | $27.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.